Priya Singh

Priya Singh was a Master of Science student at SRM Institute of Science and Technology during 2017 - 2019. She has done her Master's dissertation titled "Role of combined inhibition of SIRT1 and PRMT1 in Tamoxifen exposed Breast cancer" under Dr. Jesu Arockiaraj. She is a Ph.D. student in the Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh. She also worked as Junior Research Fellow in a project titled "An open-label, multicenter, Phase-IV clinical trial to evaluate the safety and efficacy of Daclatasvir and Sofosbuvir in patients with Chronic Hepatitis C genotype 3 infection".